1995
DOI: 10.1161/01.cir.92.7.1947
|View full text |Cite
|
Sign up to set email alerts
|

Trandolapril Decreases Prevalence of Ventricular Ectopic Activity in Middle-Aged SHR

Abstract: After trandolapril treatment, the regression of VPB incidence not only is linked to hypertrophy and fibrosis, but additional causal factors also are involved including the myocardial phenotype and new calcium metabolism. Our model of Holter monitoring in conscious middle-aged SHR and multivariate data analysis might be useful in correlating myocardial structural modifications and ectopic activity.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
17
0

Year Published

1997
1997
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(20 citation statements)
references
References 28 publications
3
17
0
Order By: Relevance
“…This effect of ACE inhibitors seems not to be restricted to aging. In fact, a significant reduction in the incidence of ectopic beats has been observed in experimental (33,34) and clinical (35) arterial hypertension, acute myocardial infarction (36) and congestive heart failure (37) after chronic ACE inhibition. There are a number of hypotheses to explain this antiarrhythmic effect.…”
Section: Discussionmentioning
confidence: 99%
“…This effect of ACE inhibitors seems not to be restricted to aging. In fact, a significant reduction in the incidence of ectopic beats has been observed in experimental (33,34) and clinical (35) arterial hypertension, acute myocardial infarction (36) and congestive heart failure (37) after chronic ACE inhibition. There are a number of hypotheses to explain this antiarrhythmic effect.…”
Section: Discussionmentioning
confidence: 99%
“…Left ventricular dimensions were determined with an image analyzer (Nachet NS 15000, Nachet-Vision, les Ulis, France; ref. 26 …”
Section: Methodsmentioning
confidence: 99%
“…A daily dose of 1 mg/kg per day trandolapril has previously demonstrated its efficiency in reducing cardiac hypertrophy in SHR. 5,10 …”
Section: Animal Model and Experimental Protocolmentioning
confidence: 99%
“…5 Briefly, with the rats anesthetized (Na ϩ pentobarbital, 25 mg/kg IP), an emitter (ETA-F20, Data Sciences) was subcutaneously implanted in the abdomen. Two leads were placed in the direction of the forelimbs to obtain a derivation similar to lead II in humans.…”
Section: Ecg Monitoring and Measurement Of Heart Rate Variabilitymentioning
confidence: 99%